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ess: katsurah@saikurl.oSummary This study evaluated the effects of body weight on both generic and
disease-specific health-related quality of life (HRQoL) of patients with COPD. A total
of 83 patients with stable COPD were enrolled (mean age: 74.6 yr, mean FEV1:
1.29 L). Patients were divided into two groups according to body mass index (BMI)
(UW group: BMI%20, NW group: 20oBMI%26). The degree of dyspnea and both
disease-specific and generic HRQoL were compared between the two groups. An
oxygen cost diagram (OCD) was used to assess the degree of dyspnea and St.
George’s Respiratory Questionnaire (SGRQ) and Medical Outcomes Study Short Form
36-item Questionnaire (SF-36) were used for HRQoL evaluation. The OCD was
significantly lower in the UW group. Compared with the NW group, the UW group
showed significant deterioration in the total score and three subscales of SGRQ. SF-
36 also showed significantly worse scores for the parameters of physical functioning,
role emotional, bodily pain, and general health. The results of stepwise multiple
regression analysis showed that OCD, FEV1, %pred. BMI were independent variables
in the total score on SGRQ. The results of stepwise multiple regression analysis also
showed that OCD was an independent variable for four of eight components of SF-36,
while BMI was three of eight components of SF-36. In conclusion, low body weight in
patients with COPD is related to a worsening of dyspnea and deterioration of bothElsevier Ltd. All rights reserved.
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Body weight and quality of life in COPD 625generic and disease-specific HRQoL. The present results also indicate that nutritional
intervention may be important for improving dyspnea and HRQoL in patients with
COPD.
& 2004 Elsevier Ltd. All rights reserved.Introduction
Patients with advanced COPD frequently lose
weight and become malnourished. Nutritional
depletion becomes a significant problem in patients
with COPD.1–3 This malnourished status in patients
with COPD causes deterioration of exercise perfor-
mance,4,5 respiratory muscle function,6 and in-
creases mortality.7,8
Health-related quality of life (HRQoL) is an
important domain of measuring the impact of
chronic diseases.9 Both generic and disease-specific
instruments have been used for measuring HRQoL
and both disease-specific and generic HRQoL are
known to be deteriorated in patients with COPD.10
Although the effects of nutritional status on the
mortality of patients with COPD is well established,
little is known about its effects on HRQoL. A study
by Shoup and coworkers11 showed that body weight
and lean body mass abnormalities influence dis-
ease-specific HRQoL in patients with COPD. How-
ever, whether a malnourished status itself affects
generic HRQoL is not known.
The present study assessed deterioration of both
generic and disease-specific HRQoL in groups of
normal weight and underweight patients with
stable COPD and investigated whether body weight
is a determinant of HRQoL in COPD patients.Methods
Subjects
Consecutive stable COPD patients, who received
monthly regular follow-up in the outpatient clinic
of the Pulmonary Division of Tokyo Metropolitan
Geriatric Medical Center (a main teaching hospital
and major referral center in the Tokyo area)
between January 2000 and December 2000, who
met the following criteria were studied: (1) stable
COPD, (2) an FEV1/FVC ratio less than 70%, and (3)
body mass index (BMI) of less than 26 kg/m2. COPD
was diagnosed according to the definition by the
American Thoracic Society.12 Clinical stability was
defined as being without acute exacerbation and
without changes in treatment regimen during the
preceding 4 weeks. Patients with comorbidities
affecting nutritional status and body weight such asmalignancies, malabsorption, endocrine disorders,
chronic renal failure, cardiac diseases, and neuro-
muscular diseases were excluded. Cognitive dis-
order was assessed by Mini Mental State
Examination (MMSE) and patients with an MMSE
less than 24 were excluded.13 Based on body mass
index (BMI), subjects were divided into two groups:
normal weight (NW group: 20oBMI%26 kg/m2) and
underweight (UW group: BMI%20 kg/m2). The hos-
pital ethics committee approved the study, and
informed consent was obtained from all subjects.Measurements
Body height was measured to the nearest 0.5 cm by
a stadiometer with the patient stood barefoot, feet
together, at the head level. Body weight was
measured on a balance beam platform scale while
the patients wore light clothing without shows. BMI
was calculated as body weight divided by body
height squared (kg/m2).
Forced expiratory volume in one second (FEV1)
and forced vital capacity (FVC) were measured
using a pulmonary function instrument with com-
puter processing (CHESTAC; CHEST Co, Tokyo,
Japan), which fulfills the American Thoracic Society
recommendation for diagnostic spirometry.14 The
largest FEV1 and FVC values from three maneuvers
were then analyzed. The predicted value of FEV1
(FEV1, %pred.) was calculated according to the
Japanese Respiratory Society proposal.15 To assess
dyspnea, Oxygen Cost Diagram (OCD) was used.16
The score ranges from 0 to 100; a score of 0
indicates maximal dyspnea.16 To assess exercise
capacity, the six-minutes walking distance test
(6MWD) was applied using the standard protocol.17
HRQoL was assessed by the Japanese version of
the St. George’s Respiratory Questionnaire
(SGRQ),18,19 and SF-36 (Medical Outcomes Study
Short Form 36-item Questionnaire).20,21 The valid-
ity of the Japanese version of the SGRQ18,19 and the
Japanese version of SF-3620,21 were previously
evaluated. The SGRQ includes 76 items that are
weighted to produce three component scores
(symptoms, activity and impact) and a total score.
Each of these scores ranges 0–100; a score of 100
indicates maximal disability.22 The SF-36 incorpo-
rates 36 items and yields eight separate subscales
including physical functioning, role physical, bodily
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role emotional, and mental health. Each subscale
score ranges from 0 to 100, with 100 representing
the most desirable score.20,21Statistical analysis
Unpaired Student’s t-tests and confidence intervals
(CI) were used for comparisons between the NW
group and the UW group. Pearson’s correlation
coefficient was used to determine the relationship
between HRQoL measures and clinical variables.
Stepwise multiple regression analysis was per-
formed to determine independent variables of
HRQoL measures. Data are expressed as means7SE,
and P-values less than 0.05 are considered sig-
nificant.Figure 1 Comparison of the SGRQ between UW and NW
groups: The UW group showed significantly higher (i.e.,
greater impairment) in activity (Po0.05), symptoms
(Po0.05), impact (Po0.05), and total score (Po0.05)
than the NW group.Results
Patient characteristics
Patient characteristics are shown in Table 1. Eighty-
three consecutive COPD patients (male: 73, fe-
male: 10) were studied. Mean age was 74.670.7
years, and mean FEV1 was 1.2970.05 L. In 49 (59%)
patients, BMI was within the normal range (normal
weight group: NW group) and in 34 (41%), BMI was
low (underweight group: UW group). Comparison of
patient characteristics between two groups are
shown in Table 1. As shown in Table 1, age, height,
and degree of airflow obstruction were similar in
two groups. However, when compared with the NW
group, UW group significantly showed low body
weight (Po0.0001), low BMI (Po0.0001), andTable 1 Patient characteristics in the study group.
Total
(n ¼ 83)
Age (yrs) 74.670.7
Male/Female 73/10
FEV1 (L) 1.2970.05
FEV1, %pred 53.9722.2
6MWD (m) 376.679.0
Body weight (kg) 55.271.0
Body height (m) 1.6070.01
BMI (kg/m2) 20.870.3
OCD 71.472.1
*Po0.05 compared with NW group.
yPo0.0001 compared with NW group.
zPo0.001 compared with NW group.deterioration of exercise capacity assessed by
6MWD (Po0.05).
Comparison of the degree of dyspnea
Comparison of the degree of dyspnea assessed by
OCD between the NW group and UW group are
shown in Table 1. The severity of dyspnea by OCD
was significantly lower (i.e., more dyspneic) in the
UW group compared with the NW group (difference
of the mean: 15.24, 95%CI: 22.97 to 7.51,
Po0.001).
Comparison of the HRQoL measures
Comparison of the SGRQ total score and three
subscores between the NW group and UW group are
shown in Fig. 1. The UW group showed significantly
higher (i.e., greater impairment) in activityNW group UW group
(n ¼ 49) (n ¼ 34)
74.770.9 74.571.2
43/6 30/4
1.2970.08 1.2970.08
53.672.8 54.373.6
396.079.4 348.7718.3*
58.471.0 45.870.9y
1.5970.07 1.6070.07
22.970.3 17.970.3y
77.672.3 62.473.3z
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Figure 2 Comparison of SF-36 between UW and NW groups: The UW group significantly lower (i.e., greater impairment)
in physical functioning (Po0.05), role emotional (Po0.05), bodily pain (Po0.001), general health (Po0.05) than the
NW group.
Table 2 Correlation between SGRQ and clinical
variables.
SGRQ
components
OCD BMI FEV1,%
pred
6MWD
Total 0.50* 0.33y 0.38** 0.38**
Symptom 0.26z 0.14 0.22 0.13
Activity 0.52* 0.34y 0.41** 0.43*
Impact 0.47* 0.31y 0.27z 0.39**
*Po0.0001,
**Po0.001,
yPo0.01,
zPo0.05.
Body weight and quality of life in COPD 627(difference of the mean: 13.06, 95%CI: 3.80–22.33,
Po0.05), symptoms (difference of the mean: 9.28,
95%CI: 0.10–18.50, Po0.01), impact (difference of
the mean: 14.44, 95%CI: 6.01–22.87, Po0.05), and
total score (difference of the mean: 12.83, 95%CI:
5.04–20.61, Po0.05) than the NW group. Compar-
ison of SF-36 scores between the NW group and UW
group are shown in Fig. 2. The UW group showed
significantly lower scores (i.e., greater impair-
ment) for physical functioning (difference of the
mean: 14.15, 95%CI: 25.43 to 2.88, Po0.05),
role emotional (difference of the mean: 24.63,
95%CI: 43.96 to 5.30, Po0.05), bodily pain
(difference of the mean: 21.46, 95%CI: 33.41 to
9.51, Po0.001), general health (difference of the
mean: 11.16, 95%CI: 20.13 to 2.19, Po0.05)
than the NW group. Compared with the NW group,
there was a tendency for the subcomponents of SF-
36 such as social functioning (difference of the
mean: 5.91, 95%CI: 17.37 to 5.56, NS), role
physical (difference of the mean: 18.04, 95%CI:
36.81 to 0.73, NS), mental health (difference of
the mean: 10.02, 95%CI: 22.09 to 2.04, NS),
and vitality (difference of the mean: 9.21, 95%CI:
19.68 to 1.27, NS) to be lower in the UW group.Correlation between the HRQoL measures
and clinical variables
Relationship between body weight category and
OCD, FEV1, %pred., and 6MWD were examined.
Both OCD and 6MWD significantly correlated with
BMI (BMI vs. OCD; r ¼ 0:35; Po0.01, BMI vs.
6MWD; r ¼ 0:34; Po0.01). However, FEV1, %pred.
did not correlate with BMI(r ¼ 0:10).Relationship between HRQoL measures and var-
ious clinical variables are examined. Relationship
between the HRQoL measures by the SGRQ and
clinical variables are shown in Table 2. Dyspnea
assessed by OCD significantly correlated with total
score and three components of the SGRQ. BMI,
6MWD, and FEV1, %pred. significantly correlated
with total score and activity and impact of SGRQ,
however, these variables did not correlate with
symptoms score of the SGRQ.
Stepwise multiple regression analysis was used to
identify those variables that may predict total
score on the SGRQ. Variables such as OCD, FEV1,
%pred., and BMI were adopted as independent
variables in analyzing the total score on the SGRQ
(OCD; r2 ¼ 0:25; FEV1, %pred. r2 ¼ 0:06; BMI;
r2 ¼ 0:04).
Correlations for the components for the SF-36
and clinical variables are shown in Table 3. OCD was
significantly correlated with six components of the
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Table 3 Correlation between SF-36 and clinical variables.
SF-36 components OCD BMI FEV1,% pred 6MWD
Physical functioning 0.48* 0.24z 0.24z 0.42*
Social functioning 0.24z 0.05 0.22z 0.21
Role physical 0.40** 0.21 0.19 0.22z
Role emotional 0.26z 0.29y 0.11 0.12
Mental health 0.07 0.18 0.17 0.13
Bodily pain 0.27z 0.32y 0.06 0.25z
Vitality 0.17 0.18 0.21 0.13
General health 0.36** 0.29y 0.32y 0.21
*Po0.0001,
**Po0.001,
yPo0.01,
zPo0.05.
H. Katsura et al.628SF-36 including physical functioning (Po0.0001),
social functioning (Po0.05), role physical
(Po0.001), role emotional (Po0.05), bodily pain
(Po0.05), and general health (Po0.001). However,
BMI was significantly correlated with only four
components: physical functioning (Po0.05), role
emotional (Po0.01), bodily pain (Po0.01), and
general health (Po0.01).
Stepwise multiple regression analysis was used to
identify those variables that may predict each
component of the SF-36. Multiple regression analy-
sis showed that the OCD was a significant indepen-
dent variable for four of eight components of the
SF-36 including physical functioning (r2 ¼ 0:23),
social functioning (r2 ¼ 0:06), role physical
(r2 ¼ 0:16), and general health (r2 ¼ 0:13). BMI
was also an independent variable for three of eight
components of the SF-36 including role emotional
(r2 ¼ 0:09), bodily pain (r2 ¼ 0:10), and general
health (r2 ¼ 0:10). Both FEV1, %pred. and 6MWD
were not predicted variable of any components of
the SF-36.Discussion
In the present study, we demonstrated that low
body weight was associated with increased dyspnea
and poor HRQoL assessed by both SGRQ and SF-36.
This is the first report to clearly show that
malnutritional status has a significant impact on
both generic and disease specific HRQoL in patients
with COPD.
Although a malnourished status is a common
problem in COPD patients,1–3 there are few studies
evaluating the effects of nutritional status on
HRQoL in patients with COPD. Shoup and coworkersevaluated body weight and composition in patients
with obstructive lung disease and compared these
to HRQoL assessed by SGRQ.11 They showed that
underweight and overweight patients and patients
with reduced lean mass had significantly reduced
disease specific HRQoL compared with normal
weight patients and patients with normal lean
mass. A similar relationship between tissue deple-
tion and deterioration of disease-specific HRQoL
was reported by Mostert et al.23 Our study added
the information that low body weight was a
significant contributor for not only disease-specific
but also generic HRQoL in patients with COPD.
The present study showed that the UW group
showed significantly more dyspneic compared with
NW group (Table 1). Traditionally, COPD patients
are divided into two clinical subtypes namely ‘‘pink
puffers’’ and ‘‘blue bloaters’’.24 Pink puffers are
described as a thin, cachexic, and dyspneic
patients with emphysema. Our results confirm that
patients with COPD who are distinguished as ‘‘pink
puffers’’ and who are characterized as malnour-
ished are more dyspneic than COPD patients with
normal weight. These finding support the results by
Sahebjami et al.25 who showed that under weight
COPD patients demonstrated significantly higher
Medical Research Council dyspnea scale than
normal weight COPD patients.
According to the correlation data between
clinical variables and disease-specific HRQoL as-
sessed by SGRQ (Table 2), the most significant
factor related to disease-specific HRQoL was
dyspnea. The multiple regression data showed that
dyspnea assessed by OCD was the greatest con-
tributing factor to the total score on the SGRQ and
that this variable explained 25% of total score on
the SGRQ. This finding is in agreement with a study
by Shoup et al.11 that dyspnea is the most
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Body weight and quality of life in COPD 629important factor affecting disease-specific HRQoL
measured by SGRQ.
On comparison of the total score and three
components of the SGRQ between the UW and NW
groups, the total score and three components of
the SGRQ were significantly higher in the UW group.
Although the contribution of BMI is weaker than the
degree of dyspnea, our multiple regression analysis
also demonstrated that BMI is an independent
variable affecting the total score of the SGRQ.
These results suggest that the importance of
nutritional status on disease specific HRQoL in
patients with COPD.
According to the correlation data between
clinical variables and generic HRQoL assessed by
SF-36, OCD correlated with six of eight subscale of
SF-36, suggesting that dyspnea was a highly
significant factor affecting generic HRQoL in pa-
tients with COPD. This finding is in agreement with
a study by Mahler and coworkers26 showing that
dyspnea is a highly significant factor affecting
generic HRQoL measured by SF-36. However, on
comparison of eight subscales of SF-36 between UW
and NW groups, scores on subscales such as physical
functioning, role emotional, bodily pain, general
health were significantly lower in the UW group.
Multiple regression analysis also showed that BMI
was an independent variable affecting role emo-
tional, bodily pain and general health and that BMI
was the only variable affecting scores on role
emotional and bodily pain subscales of SF-36. These
findings suggest that not only the degree of dyspnea
but also malnourished status are important vari-
ables determining generic HRQoL. These findings
also suggest that both low body weight and dyspnea
influence different aspects of generic HRQoL.
It is well known that a normal weight individual
with COPD is at significant risk for having reduced
fat-free or lean mass and this deficiency is also
related to increased morbidity.27,28 Schols et al.27
reported that 10% of COPD patients had normal
weight with fat-free mass depletion. The study by
Mostert et al.23 showed that COPD patients who had
normal weight with fat-free mass depletion demon-
strated significant deterioration in activity, impact-
ing scores on the SGRQ. Our study only examined
the correlation between body weight categories
and generic and disease-specific HRQoL. It is not
clear whether COPD patients maintaining normal
weight with fat-free mass depletion demonstrated
deterioration in generic HRQoL. Further study is
needed to evaluate correlation between generic
HRQoL and tissue depletion.
Considering the contribution of low body weight
to both generic and disease specific HRQoL,
nutritional intervention should be included in thetreatment for COPD. However, a recent meta-
analysis including nine randomized controlled trial
showed that the clinical effectiveness of nutritional
intervention is not significant.29 The outcome
measures assessed in these trials included body
weight, arm muscle circumference, triceps skin-
fold thickness, the 6MWD, FEV1, maximal inspira-
tory pressure, and maximal expiratory pressure.
However, these trials did not include HRQoL as an
outcome measure. The present results emphasize
the importance of measuring HRQoL in underweight
patients with COPD and the outcomes of nutrional
intervention should be assessed in this regard.
Some limitations of this study should be dis-
cussed. In this study, to determine disease specific
HRQoL, we used the Japanese version of the SGRQ
in a Japanese population. One may concern as to
whether Japanese version of the SGRQ behaves in
the same manner as original English version. When
HRQoL questionnaires are translated into other
languages, careful translation and back translation
procedures are necessary to maintain similar
discriminative properties and responsiveness.30
The Japanese version of the SGRQ was translated
into this procedure and it has been reported that
the Japanese version of the SGRQ appeared to
perform in a similar manner to the English
originals.19,22 These facts indicated that the Japa-
nese version of the SGRQ have similar discrimina-
tive properties and responsiveness as original
English versions. However, when translating English
version of HRQoL questionnaires into another
languages, some cultural differences may influence
the translation of HRQoL questionnaires.30 It is not
clear whether the results shown in this study could
apply in another populations such as English speak-
ers. Generalization of these results to population of
another languages should be examined.
In conclusion, our results indicated that low body
weight in COPD patients is related to worsening of
dyspnea and deterioration of both generic and
disease-specific HRQoL. The present results also
indicate that nutritional intervention may be
important for improving dyspnea and HRQoL in
patients with COPD. Further longitudinal study is
needed to clarify these findings.Acknowledgements
The authors would like to thank Ritsuko Wakabaya-
shi, RN for conducting the HRQoL measurements.
We would also like to thank Koichi Nishimura MD
(Pulmonary Division, Kyoto Katsura Hospital, Kyoto,
Japan), and Shyunnichi Fukuhara, MD (Graduate
ARTICLE IN PRESS
H. Katsura et al.630School of Medicine, Kyoto University, Kyoto, Japan)
for permission to use the Japanese versions of SGRQ
and SF-36. We also thank Tatsuo Kagimura, Ph.D.
(Medical Data Services Department, Biometrics
Group, Japan Boehringer Ingelheim). This study
was supported by a grant from the Pollution-
Related Health Damage Compensation and Preven-
tion Association of Japan.References
1. Wilson DO, Rogers RM, Wright EC, et al. Body weight in
chronic obstructive pulmonary disease. The national insti-
tutes of health intermittent positive-pressure breathing
trial. Am Rev Respir Dis 1989;139:1435–8.
2. Sahebjami H, Doers JT, Render ML, et al. Anthropometric
and pulmonary function test profiles of outpatients with
stable chronic obstructive pulmonary disease. Am J Med
1993;94:469–74.
3. Hunter AM, Carey MA, Larsh HW. The nutritional status of
patients with chronic obstructive pulmonary disease. Am
Rev Respir Dis 1981;124:376–81.
4. Schols AM, Mostert R, Soeters PB, et al. Body composition
and exercise performance in patients with chronic obstruc-
tive pulmonary disease. Thorax 1991;46:695–9.
5. Palange P, Forte S, Felli A, et al. Nutritional state and exercise
tolerance in patients with COPD. Chest 1995;107:1206–12.
6. Nishimura Y, Tsutsumi M, Nakata H, et al. Relationship
between respiratory muscle strength and lean body mass in
men with COPD. Chest 1995;107:1232–6.
7. Gray-Donald K, Gibbons L, Shapiro SH, et al. Nutritional
status and mortality in chronic obstructive pulmonary
disease. Am J Respir Crit Care Med 1996;153:961–6.
8. Katsura H, Ogata M, Kida K. Factors determining outcome in
elderly patients with severe COPD on long-term domiciliary
oxygen therapy. Monaldi Arch Chest Dis 2001;56:195–201.
9. Deyo RA. The quality of life research and care. Ann Intern
Med 1991;114:695–7.
10. Nishimura K, Tsukino M, Hajiro T. Health-related quality of
life in patients with chronic obstructive pulmonary disease.
Curr Opin Pulmonary Med 1998;4:107–15.
11. Shoup R, Dalsky G, Warner S, et al. Body composition and
health-related quality of life in patients with obstructive
airways disease. Eur Respir J 1997;10:1576–80.
12. American Thoracic Society. Standards for the diagnosis and
care of patients of chronic obstructive pulmonary disease.
Am J Respir Crit Care Med 1997;152 (Suppl):S77–S121.
13. Folstein MF, Folstein SE, McHugh PR. ‘Mini-mental state’. A
practical method for grading the cognitive state of patients
for the clinician. J Psychiatr Res 1975;12:189–98.
14. Medical section of American Lung Association. Standaliza-
tion of spirometry—1994 update. Am Rev Respir Dis 1994;
152:1107–36.15. Japanese Respiratory Society. The predicted values of
spirometry and arterial blood gas analysis in Japanese. J
Jpn Resp Soc 2001; 39: Appendix [in Japanese].
16. McGavin CR, Artvinli M, Naoe H, et al. Dyspnoea, disability,
and distance walked: comparison of estimates of
exercise performance in respiratory disease. Br Med J 1978;
2:241–3.
17. Guyatt GH, Pugsley SO, Sullivan MJ, et al. Effect of
encouragement on walking test performance. Thorax 1984;
39:818–22.
18. Hajiro T, Nishimura K, Jones PW, et al. A novel, short, and
simple questionnaire to measure health-related quality of
life in patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med 1998;159:1874–8.
19. Hajiro T, Nishimura K, Tsukino M, et al. Comparison of
discriminative properties among disease-specific question-
naires for measuring health-related quality of life in patients
with chronic obstructive pulmonary disease. Am J Respir
Crit Care Med 1998;157:785–90.
20. Fukuhara S, Bito S, Green J, et al. Translation, adaptation,
and validation of the SF-36 health survey for use in Japan. J
Clin Epidemiol 1998;51:1037–44.
21. Fukuhara S, Ware Jr JE, Kosinski M, et al. Psychometric and
clinical tests of validity of the Japanese SF-36 health survey.
J Clin Epidemiol 1998;51:1045–53.
22. Jones PW, Quirk FH, Baveystock CM, et al. A self-complete
measure of health status for chronic airflow limitation: the
St George’s respiratory questionnaire. Am Rev Respir Dis
1992;145:1321–7.
23. Mostert R, Goris A, Wellng-Scheepers C, et al. Tissue
depletion and health related quality of life in patients with
chronic obstructive pulmonary disease. Respir Med 2000;
94:859–67.
24. Filley GF. Emphysema and chronic bronchitis: clinical
manifestations and their physiologic significance. Med Clin
North Am 1967;51:283–92.
25. Sahebjami H, Sathianpitayakul E. Influence of body
weight on the severity of dyspnea in chronic obstructive
pulmonary disease. Am J Respir Crit Care Med 2000;161:
886–90.
26. Mahler DA, Mackowiak JL. Evaluation of the short-form 36-
item questionnaire to measure health-related quality of life
in patients with COPD. Chest 1995;107:1585–9.
27. Schols AM, Soeters PB, Dingemans AMC, et al. Prevalence
and characteristics of nutritional depletion in patients with
stable COPD eligible for pulmonary rehabilitation. Am Rev
Respir Dis 1993;147:1151–6.
28. ZuWallack RL, Shoup R, Waner S, et al. Alterations in total
and regional body composition in patients with moderate to
severe obstructive lung disease. Monaldi Arch Chest Dis
1996;51:507–9.
29. Ferreria IM, Brooks D, Lacasse Y, et al. Nutritional support
for individuals with COPD—a meta-analysis. Chest
2000;117:672–8.
30. Jones PW. Testing health status (‘quality of life’) ques-
tionnaires for asthma and COPD. Eur Respir J 1998;11:5–6.
